.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Dr. Eva Ulla Lorentzen

Muenster / DE

WWU Muenster

Speaker

28/03/2023
Poster
P 068
Detection and differentiation of variant-specific antibodies against the SARS-CoV-2 spike protein using nanoluciferase-tagged RBD- and NTD-antigens in sVNT and capture EIA
Clinical virology

Further involvements

28/03/2023
Poster
P 067
Variant-specific humoral immune response in an immunocompromised patient experiencing severe, prolonged SARS-CoV-2 infection complicated by escape mutants and self-limiting Omicron re-infection
Clinical virology
28/03/2023
Poster
P 068
Detection and differentiation of variant-specific antibodies against the SARS-CoV-2 spike protein using nanoluciferase-tagged RBD- and NTD-antigens in sVNT and capture EIA
Clinical virology
28/03/2023
Poster
P 238
A virus-free reporter enzyme assay to identify antiviral drug candidates against SARS-CoV-2 spike protein mediated cell-cell fusion
Antiviral therapy and resistance, SARS-CoV-2